Occurrence of Ventilator Associated Pneumonia in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion Drainage
VICTOR
1 other identifier
interventional
100
1 country
1
Brief Summary
Ventilator-associated pneumonia (VAP) is a serious complication and carries increased risks of morbidity and mortality for patients who require mechanical ventilation. VAP is associated with the contamination and colonization of bacteria in the lower airway. These bacteria may be present in the lower airway by the aspiration of oropharyngeal secretions. Therefore limiting the amount of secretions that pass the glottis and enter the airway is paramount. Patients who require prolonged mechanical ventilation may have a tracheostomy tube placed to manage breathing. These tubes may have a distal cuff which sits within the trachea. When the cuff is inflated, oropharyngeal secretions will pool above the cuff of the tracheostomy tube thereby limiting the amount of secretions entering the lower airway. These secretions may leak around the cuff and cause tracheobronchial colonization. It has been shown that removal of secretions that pool above the cuff via dorsal lumen suction leads to a decreased incidence of VAP. The purpose of this study is to measure the effect of suction above the cuff tracheostomy tubes related to VAP incidence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 21, 2014
CompletedFirst Posted
Study publicly available on registry
August 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedMay 9, 2017
May 1, 2017
1.9 years
August 21, 2014
May 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of VAP
at 28 days
Secondary Outcomes (4)
Mortality rate
at 28 days
Duration of mechanical ventilation
30 days
ICU length of stay
30 days
Ventilator free days after tracheostomy
28 days
Study Arms (1)
subglottic secretion drainage
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients on mechanical ventilation for respiratory failure for at least 72 hours.
- A score of 35 to 65 on the Simplified Acute Physiology Score II (SAPS II).
- Does not have a pulmonary infection estimated by a Clinical Pulmonary Infection Score (CPIS).
- Age \>= 18 years.
You may not qualify if:
- A history of esophageal, tracheal or pulmonary cancer or an existing malignancy within the trachea at the tracheostomy site.
- Previous surgery at the tracheostomy site (e.g. thyroidectomy).
- Bleeding diathesis (e.g. due to anticoagulation therapy).
- Emergency surgical airway management.
- Morbid obesity and/or neck edema (skin to trachea distance may render tracheostomy tube too short).
- Pre-existing infection at the tracheostomy site.
- Uncertainty in identifying the anatomical landmarks.
- Patients with a do not resuscitate order.
- Immunosuppressed and/or immunodepressed patients (Immunodepression being defined by the following conditions: 1-Leukocytes \< 1000/µl, 2-Neutrophils \< 500/µl. 3-AIDS Long-term steroid treatment (daily dose \> 0.5 mg/kg) for more than 30 days)
- Patients already enrolled in other trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Turin - Department of Anesthesia and Intensive Care Medicine
Turin, 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierpaolo Terragni, MD
Department of Anesthesia and Intensive Care Medicine, University of Turin, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 21, 2014
First Posted
August 22, 2014
Study Start
July 1, 2014
Primary Completion
June 1, 2016
Study Completion
July 1, 2016
Last Updated
May 9, 2017
Record last verified: 2017-05